search
Back to results

Effect of High Frequency Oscillatory Highflow Nasal Cannula on Desaturations and Bradycardia in Preterm Infants (Osciflow)

Primary Purpose

Apnea of Prematurity, Infant, Premature, Diseases

Status
Completed
Phase
Not Applicable
Locations
Switzerland
Study Type
Interventional
Intervention
Osciflow
Highflow
Sponsored by
University of Zurich
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Apnea of Prematurity focused on measuring Non-invasive respiratory support, Non-invasive high frequency oscillatory ventilation, Highflow nasal cannula

Eligibility Criteria

3 Days - undefined (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Preterm infants born with a gestational age of <35 weeks
  • >72 hours old
  • On nCPAP with PEEP 5 mbar and FiO2 <0.3

Exclusion Criteria:

  • Severe congenital malformations adversely affecting life expectancy

Sites / Locations

  • Department of Neonatology, University Hospital Zurich

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Osciflow

Highflow

Arm Description

Crossover sequence of experimental treatment and active comparator.

Crossover sequence of experimental treatment and active comparator.

Outcomes

Primary Outcome Measures

Paired difference in the total number of desaturations and bradycardia between Osciflow and HF

Secondary Outcome Measures

Paired difference in respiratory rate
Paired difference in heart rate
Paired difference in fraction of inspired oxygen [FiO2]
Paired difference in peripheral oxygen saturation [SpO2]
Paired difference in the proportion of time spent with oxygen saturations < 80%
Paired difference in the proportion of time spent with heart rates < 80 bpm
Paired difference in the number of apneas requiring stimulation
Paired difference in transcutaneous CO2 measurements
Paired difference in pain assessment using 'Bernese pain scale'
Bernese Pain-Scale for Neonates (BPSN): a 9-item multidimensional pain assessment tool that includes behavioral and physiological indicators. The instrument consists of seven subjective (alertness, crying, consolation, skin color, facial expression, posture, and changes in respiratory rate) and two physiological (i.e. objective) (changes in heart rate and oxygen saturation) indicators. Each item is rated on a four point Likert scale (0, 1, 2, and 3). Higher scores indicate greater pain-related distress, and a total score of 11 or higher is considered to indicate pain.
Paired difference in end-expiratory lung impedance (EELI) in a subset of patients.
EELI using electrical impedance tomography (arbitrary units per kilogram).
Paired difference in regional ventilation distribution in a subset of patients.
Regional ventilation distribution using electrical impedance tomography (arbitrary units per kilogram).
Paired difference in Tidal volumes in a subset of patients.
Tidal volumes using electrical impedance tomography (arbitrary units per kilogram).
Paired difference in nasal trauma score
Royal Women's Hospital Nasal Integrity and Pressure Chart. Nasal injury is defined as stage 0-skin intact; stage 1-nonblanchable erythema of intact skin; stage 2-partial thickness skin loss involving epidermis, dermis, or both; stage 3-full thickness skin loss involving damage to or necrosis of subcutaneous tissue; stage 4-full thickness skin loss with extensive destruction, tissue necrosis, or damage to supporting structures. Lowest Score: 0. Highest Score: 4. A higher score indicates more extensive nasal injury.
Paired difference in the rate of pneumothorax
Paired difference in reaching 'failure criteria' to stop Osciflow or HF therapy:
Definition of failure criteria Respiratory rate >90/min for more than 30 minutes Respiratory rate >20/min higher than at the beginning of the study Increase in FiO2 by ≥ 0.25 from baseline for more than 30 minutes Apnea-Score of more than 20/4 hours

Full Information

First Posted
March 12, 2020
Last Updated
January 12, 2022
Sponsor
University of Zurich
search

1. Study Identification

Unique Protocol Identification Number
NCT04327466
Brief Title
Effect of High Frequency Oscillatory Highflow Nasal Cannula on Desaturations and Bradycardia in Preterm Infants
Acronym
Osciflow
Official Title
Effect of High Frequency Oscillatory Highflow Nasal Cannula on Desaturations and Bradycardia in Preterm Infants: A Randomized Crossover Trial
Study Type
Interventional

2. Study Status

Record Verification Date
January 2022
Overall Recruitment Status
Completed
Study Start Date
May 22, 2020 (Actual)
Primary Completion Date
November 26, 2021 (Actual)
Study Completion Date
November 26, 2021 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Zurich

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
This study evaluates the effect of non-invasive high frequency oscillations applied via a highflow nasal cannula ('Osciflow') compared to highflow nasal cannula without oscillations (HF) on desaturations and bradycardia in premature infants. It uses a crossover design. Infants are randomized to begin the study with either Osciflow or HF. Both modes are applied for 4 hours. Infants are monitored with an oximetry sensor to measure peripheral oxygen saturation (SpO2) and pulse rate, and with a transcutaneous CO2-transducer. Further measurements include respiratory rate and 'Bernese pain scale' evaluated by nursing staff and Electrical Impedance Tomography (EIT) in a subset of patients.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Apnea of Prematurity, Infant, Premature, Diseases
Keywords
Non-invasive respiratory support, Non-invasive high frequency oscillatory ventilation, Highflow nasal cannula

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
30 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Osciflow
Arm Type
Experimental
Arm Description
Crossover sequence of experimental treatment and active comparator.
Arm Title
Highflow
Arm Type
Active Comparator
Arm Description
Crossover sequence of experimental treatment and active comparator.
Intervention Type
Device
Intervention Name(s)
Osciflow
Intervention Description
Osciflow is a non-invasive high frequency oscillatory ventilation support delivered via a highflow nasal cannula for four hours (one hour wash-out, three hours measurement period).
Intervention Type
Device
Intervention Name(s)
Highflow
Intervention Description
Standard highflow therapy without oscillations delivered via a highflow nasal cannula for four hours (one hour wash-out, three hours measurement period).
Primary Outcome Measure Information:
Title
Paired difference in the total number of desaturations and bradycardia between Osciflow and HF
Time Frame
180-minute recording periods for each therapy
Secondary Outcome Measure Information:
Title
Paired difference in respiratory rate
Time Frame
180-minute recording periods for each therapy
Title
Paired difference in heart rate
Time Frame
180-minute recording periods for each therapy
Title
Paired difference in fraction of inspired oxygen [FiO2]
Time Frame
180-minute recording periods for each therapy
Title
Paired difference in peripheral oxygen saturation [SpO2]
Time Frame
180-minute recording periods for each therapy
Title
Paired difference in the proportion of time spent with oxygen saturations < 80%
Time Frame
180-minute recording periods for each therapy
Title
Paired difference in the proportion of time spent with heart rates < 80 bpm
Time Frame
180-minute recording periods for each therapy
Title
Paired difference in the number of apneas requiring stimulation
Time Frame
180-minute recording periods for each therapy
Title
Paired difference in transcutaneous CO2 measurements
Time Frame
180-minute recording periods for each therapy
Title
Paired difference in pain assessment using 'Bernese pain scale'
Description
Bernese Pain-Scale for Neonates (BPSN): a 9-item multidimensional pain assessment tool that includes behavioral and physiological indicators. The instrument consists of seven subjective (alertness, crying, consolation, skin color, facial expression, posture, and changes in respiratory rate) and two physiological (i.e. objective) (changes in heart rate and oxygen saturation) indicators. Each item is rated on a four point Likert scale (0, 1, 2, and 3). Higher scores indicate greater pain-related distress, and a total score of 11 or higher is considered to indicate pain.
Time Frame
180-minute recording periods for each therapy
Title
Paired difference in end-expiratory lung impedance (EELI) in a subset of patients.
Description
EELI using electrical impedance tomography (arbitrary units per kilogram).
Time Frame
At the end of each intervention period
Title
Paired difference in regional ventilation distribution in a subset of patients.
Description
Regional ventilation distribution using electrical impedance tomography (arbitrary units per kilogram).
Time Frame
At the end of each intervention period
Title
Paired difference in Tidal volumes in a subset of patients.
Description
Tidal volumes using electrical impedance tomography (arbitrary units per kilogram).
Time Frame
At the end of each intervention period
Title
Paired difference in nasal trauma score
Description
Royal Women's Hospital Nasal Integrity and Pressure Chart. Nasal injury is defined as stage 0-skin intact; stage 1-nonblanchable erythema of intact skin; stage 2-partial thickness skin loss involving epidermis, dermis, or both; stage 3-full thickness skin loss involving damage to or necrosis of subcutaneous tissue; stage 4-full thickness skin loss with extensive destruction, tissue necrosis, or damage to supporting structures. Lowest Score: 0. Highest Score: 4. A higher score indicates more extensive nasal injury.
Time Frame
At the end of each intervention period
Title
Paired difference in the rate of pneumothorax
Time Frame
180-minute recording periods for each therapy
Title
Paired difference in reaching 'failure criteria' to stop Osciflow or HF therapy:
Description
Definition of failure criteria Respiratory rate >90/min for more than 30 minutes Respiratory rate >20/min higher than at the beginning of the study Increase in FiO2 by ≥ 0.25 from baseline for more than 30 minutes Apnea-Score of more than 20/4 hours
Time Frame
180-minute recording periods for each therapy

10. Eligibility

Sex
All
Minimum Age & Unit of Time
3 Days
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Preterm infants born with a gestational age of <35 weeks >72 hours old On nCPAP with PEEP 5 mbar and FiO2 <0.3 Exclusion Criteria: Severe congenital malformations adversely affecting life expectancy
Facility Information:
Facility Name
Department of Neonatology, University Hospital Zurich
City
Zurich
ZIP/Postal Code
8091
Country
Switzerland

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
31339005
Citation
Rub DM, Sivieri EM, Abbasi S, Eichenwald E. Effect of high-frequency oscillation on pressure delivered by high flow nasal cannula in a premature infant lung model. Pediatr Pulmonol. 2019 Nov;54(11):1860-1865. doi: 10.1002/ppul.24459. Epub 2019 Jul 24.
Results Reference
background
PubMed Identifier
30549451
Citation
Sivieri EM, Eichenwald E, Bakri SM, Abbasi S. Effect of high frequency oscillatory high flow nasal cannula on carbon dioxide clearance in a premature infant lung model: A bench study. Pediatr Pulmonol. 2019 Apr;54(4):436-443. doi: 10.1002/ppul.24216. Epub 2018 Dec 14.
Results Reference
background

Learn more about this trial

Effect of High Frequency Oscillatory Highflow Nasal Cannula on Desaturations and Bradycardia in Preterm Infants

We'll reach out to this number within 24 hrs